Immunotherapy could extend lives of advanced prostate cancer patients

One in 20 men with advanced unresponsive prostate cancer respond to immunotherapy in clinical trial Related items fromOnMedica Is crowdfunding for cancer patients paying for ‘quackery’? Cancer patients using complementary meds die sooner Men ’s dementia risk higher after androgen deprivation therapy Wales cancer spend at record high Only half of new cancer drugs extend or improve life
Source: OnMedica Latest News - Category: UK Health Source Type: news